Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

BACKGROUND: Fluticasone furoate (FF) is a novel long-acting inhaled corticosteroid (ICS). This double-blind, placebo-controlled randomized study evaluated the efficacy and safety of FF 200 mcg or 400 mcg once daily, either in the morning or in the evening, and FF 200 mcg twice daily (morning and eve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Woodcock, Ashley, Bateman, Eric D, Busse, William W, Lötvall, Jan, Snowise, Neil G, Forth, Richard, Jacques, Loretta, Haumann, Brett, Bleecker, Eugene R
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3217852/
https://ncbi.nlm.nih.gov/pubmed/21977941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-12-132
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados